Second Affiliated Hospital Of Guangzhou Medical University
Clinical trials sponsored by Second Affiliated Hospital Of Guangzhou Medical University, explained in plain language.
-
Gene therapy hopes to tame severe childhood epilepsy
Disease control Recruiting nowThis early-stage trial tests a gene therapy called RC001 in children aged 2 to 18 with Dravet syndrome, a severe form of epilepsy caused by a genetic mutation. The therapy is given as a single injection into the spinal fluid. The main goal is to check safety and how the body proc…
Phase: EARLY_PHASE1 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jul 02, 2026 00:00 UTC
-
Can a heart drug tame sepsis? new trial aims to find out
Disease control Recruiting nowThis study tests whether ivabradine, a drug that slows heart rate without weakening the heart's pumping strength, can help people with sepsis. Sepsis is a life-threatening infection that often causes a dangerously fast heart rate. The trial will enroll 172 adults in intensive car…
Phase: PHASE4 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 12:23 UTC
-
Can triple therapy kickstart diabetes remission? new study aims to find out
Disease control Recruiting nowThis study compares two triple-drug combinations to see which works better for controlling blood sugar and possibly achieving diabetes remission in people newly diagnosed with type 2 diabetes. About 240 adults aged 18-65 with very high blood sugar (HbA1c ≥9%) will be randomly ass…
Phase: PHASE1, PHASE2 • Sponsor: Second Affiliated Hospital of Guangzhou Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:00 UTC